CYTOTOXIC T-LYMPHOCYTE RESPONSES TO RECOMBINANT CANARYPOX-GP160 MN (ALVAC VCP125, HIV-1 GP160 MN) IN HIV-1 UNINFECTED ADULT VOLUNTEERS

被引：0
|
作者：
EGAN, MA [1 ]
WEINHOLD, K [1 ]
PAOLETTI, E [1 ]
TARTAGLIA, J [1 ]
CLEMENTS, ML [1 ]
PAVLAT, W [1 ]
SILICIANO, RF [1 ]
机构：
[1] JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 1994年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [21] Megalomicin inhibits HIV-1 replication and interferes with gp160 processing
    José, ES
    Muñoz-Fernández, MA
    Alarcón, B
    VIROLOGY, 1997, 239 (02) : 303 - 314
  • [22] Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration
    Gorse, GJ
    McElrath, MJ
    Matthews, TJ
    Hsieh, RH
    Belshe, RB
    Corey, L
    Frey, SE
    Kennedy, DJ
    Walker, MC
    Eibl, MM
    VACCINE, 1998, 16 (05) : 493 - 506
  • [23] A VACCINIA-GP160-BASED VACCINE BUT NOT A GP160 PROTEIN VACCINE ELICITS ANTI-GP160 CYTOTOXIC T-LYMPHOCYTES IN SOME HIV-1 SERONEGATIVE VACCINEES
    PERALES, MA
    SCHWARTZ, DH
    FABRY, JA
    LIEBERMAN, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (01): : 27 - 35
  • [24] CHARACTERIZATION OF SERUM ANTIBODY-RESPONSES TO RECOMBINANT HIV-1 GP160 VACCINE BY ENZYME-IMMUNOASSAY
    VISCIDI, R
    ELLERBECK, E
    GARRISON, L
    MIDTHUN, K
    CLEMENTS, ML
    CLAYMAN, B
    FERNIE, B
    SMITH, G
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) : 1251 - 1256
  • [25] SERUM ANTIBODIES TO HIV-1 IN RECOMBINANT VACCINIA VIRUS RECIPIENTS BOOSTED WITH PURIFIED RECOMBINANT GP160
    MONTEFIORI, DC
    GRAHAM, BS
    KLIKS, S
    WRIGHT, PF
    JOURNAL OF CLINICAL IMMUNOLOGY, 1992, 12 (06) : 429 - 439
  • [26] ENVELOPE-SPECIFIC ANTIBODIES IN THE SALIVA OF INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-1 GP160
    VASUDEVACHARI, MB
    UFFELMAN, KW
    KOVACS, J
    YEH, CK
    LANE, HC
    SALZMAN, NP
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (08): : 817 - 821
  • [27] Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn)
    Guerra, E
    Ricci, G
    Carlesimo, M
    Varani, AR
    Pontesilli, O
    Scala, E
    Mezzaroma, I
    Pierdominici, M
    Pandolfi, F
    Antinori, A
    DeLuca, A
    Murri, R
    Ammassari, A
    Ortona, L
    Aiuti, F
    DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 147 - 154
  • [28] Linear epitope mapping of humoral responses induced by vaccination with recombinant HIV-1 envelope protein gp160
    LoomisPrice, LD
    Levi, M
    Burnett, PR
    vanHamont, JE
    Shafer, RA
    Wahren, B
    Birx, DL
    JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 1997, 19 (01): : 58 - 65
  • [29] Effect of therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA and plasma RNA: Relationship to cellular immune responses
    Kundu, SK
    Katzenstein, D
    Valentine, FT
    Spino, C
    Efron, B
    Merigan, TC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (04): : 269 - 274
  • [30] Characterization and enhancement of the interaction between HIV-1 gp120/gp160 and MBL
    Hart, ML
    Saifuddin, M
    Spear, GT
    FASEB JOURNAL, 2001, 15 (04): : A691 - A691
12345